Cellyan Biotechnology Co., Ltd (HKPD)
NASDAQ·Healthcare·Medical - Pharmaceuticals
$0.42
-6.44%
Mkt Cap $6.91M
No analyst coverage available
We don't have analyst ratings or price target data for Cellyan Biotechnology Co., Ltd yet. Coverage gaps are common for sub-$1B market caps and recently-listed names.